In addition, among the patients with HER2-enriched breast cancer, high TG levels after NAC were associated significantly with a high ALC before NAC (P = 0.021), and high TG levels before NAC were associated significantly with a high ALC after NAC (P = 0.046). This evidence concerns the gene ERBB2 and breast carcinoma.